Medicare Enrolled
Dr. Mehul Vora, MD
Endocrinology · Orland Park, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vora from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vora?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vora
Dr. Mehul Vora is an endocrinology specialist in Orland Park, IL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Vora performed 6,766 Medicare services across 2,106 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vora received a total of $9,294 from 57 pharmaceutical and/or device companies across 519 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vora is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 6% volume in IL
$9,294 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,766
Medicare services
Top 6% in IL for endocrinology
2,106
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~423 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,400 | $18 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,448 | $95 | $200 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
844 | $10 | $50 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
696 | $3 | $25 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
449 | $27 | $153 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
261 | $11 | $40 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
174 | $1 | $45 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
155 | $70 | $175 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
113 | $132 | $300 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
62 | $8 | $15 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
46 | $65 | $125 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
23 | $50 | $165 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $108 | $200 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
19 | $75 | $115 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
19 | $29 | $30 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $39 | $125 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
17 | $98 | $175 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,294
Total received (2018-2024)
Avg $1,328/year across 7 years
Top 22% in IL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
519
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,211 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$83 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,003
2023
$2,244
2022
$1,407
2021
$1,571
2020
$907
2019
$834
2018
$329
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AIMMUNE THERAPEUTICS, INC.
$386
Novo Nordisk Inc
$220
Lilly USA, LLC
$219
Abbott Laboratories
$202
Corcept Therapeutics
$191
Insulet Corporation
$128
Janssen Pharmaceuticals, Inc
$71
Bayer Healthcare Pharmaceuticals Inc.
$62
Ultragenyx Pharmaceutical Inc.
$58
Xeris Pharmaceuticals, Inc.
$56
Astellas Pharma US Inc
$49
Amgen Inc.
$44
Radius Health, Inc.
$34
SANOFI-AVENTIS U.S. LLC
$34
Rhythm Pharmaceuticals, Inc.
$28
Dexcom, Inc.
$25
Ascensia Diabetes Care Us Inc.
$24
ABBVIE INC.
$23
Acella Pharmaceuticals, LLC
$22
BETA BIONICS, INC.
$20
Alexion Pharmaceuticals, Inc.
$20
IBSA Pharma Inc.
$19
TheracosBio, LLC
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Alvogen Inc
$18
Antares Pharma, Inc.
$13
Top 3 companies account for 41.2% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,044
Novo Nordisk Inc
$787
SANOFI-AVENTIS U.S. LLC
$766
AstraZeneca Pharmaceuticals LP
$622
Abbott Laboratories
$619
NESTLE HEALTHCARE NUTRITION INC.
$459
Corcept Therapeutics
$424
AIMMUNE THERAPEUTICS, INC.
$386
Dexcom, Inc.
$367
Amgen Inc.
$361
Janssen Pharmaceuticals, Inc
$349
Insulet Corporation
$257
IBSA Pharma Inc.
$217
AbbVie Inc.
$200
MannKind Corporation
$193
Antares Pharma, Inc.
$139
Bayer Healthcare Pharmaceuticals Inc.
$137
Merck Sharp & Dohme Corporation
$135
Ultragenyx Pharmaceutical Inc.
$129
Mannkind Corporation
$125
Boehringer Ingelheim Pharmaceuticals, Inc.
$123
Xeris Pharmaceuticals, Inc.
$110
Astellas Pharma US Inc
$101
Amneal Pharmaceuticals LLC
$101
Clarus Therapeutics Inc.
$90
Alexion Pharmaceuticals, Inc.
$89
ABBVIE INC.
$85
Amarin Pharma Inc.
$75
Merck Sharp & Dohme LLC
$73
Bayer HealthCare Pharmaceuticals Inc.
$72
Radius Health, Inc.
$52
Takeda Pharmaceuticals U.S.A., Inc.
$43
Currax Pharmaceuticals LLC
$42
Ascensia Diabetes Care US Inc.
$40
Horizon Therapeutics plc
$32
Nalpropion Pharmaceuticals, Inc.
$31
AbbVie, Inc.
$31
RECORDATI_RARE_DISEASES_INC.
$31
Rhythm Pharmaceuticals, Inc.
$28
Companion Medical, Inc.
$24
Ascensia Diabetes Care Us Inc.
$24
Acella Pharmaceuticals, LLC
$22
Kyowa Kirin, Inc.
$21
BETA BIONICS, INC.
$20
Sun Pharmaceutical Industries Inc.
$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
Regeneron Healthcare Solutions, Inc.
$19
Supernus Pharmaceuticals, Inc.
$19
TheracosBio, LLC
$18
Alvogen Inc
$18
Nalpropion Pharmaceuticals LLC
$17
Tandem Diabetes Care, Inc.
$17
Amryt Pharma Holdings Ltd
$16
Shire North American Group Inc
$16
Medtronic, Inc.
$15
Azurity Pharmaceuticals, Inc.
$15
DEXCOM, INC.
$11
Top 3 companies account for 27.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · BAQSIMI · BASAGLAR · Brenzavvy · CONTRAVE · CYCLOSET · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DIFICID · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · GVOKE PFS · HUMULIN · IMCIVREE · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · LYUMJEV · Levemir · MOUNJARO · MYCAPSSA · Minimed 770G System · NATPARA · NOCDURNA · NP Thyroid 60 · OTREXUP · Omnipod · Otrexup · Ozempic · PRALUENT · Prolia · RECORLEV · RIOMET ER · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · Vascepa · Veozah · Wegovy · XARELTO · XYOSTED · ZENPEP · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
184
Per 100K population
3.5
County median income
$81,797
Nearest hospital
PALOS COMMUNITY HOSPITAL
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vora is a clinical cardiology specialist, with above-average Medicare volume (top 6% in IL), with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vora experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Vora performed 2,400 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vora receive payments from pharmaceutical companies?
Yes. Dr. Vora received a total of $9,294 from 57 companies across 519 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vora's costs compare to other endocrinologists in Orland Park?
Dr. Vora's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vora) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Orland Park
Browse endocrinologists in Orland Park ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in IL
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in IL
Which IL endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology